2,6-Bis[(2H7)-2-propanyl](O-2H4)phenol
phenol Structure](https://image.chemsrc.com/caspic/305/1189467-93-3.png)
2,6-Bis[(2H7)-2-propanyl](O-2H4)phenol structure
|
Common Name | 2,6-Bis[(2H7)-2-propanyl](O-2H4)phenol | ||
|---|---|---|---|---|
| CAS Number | 1189467-93-3 | Molecular Weight | 196.382 | |
| Density | 0.9±0.1 g/cm3 | Boiling Point | 256.0±0.0 °C at 760 mmHg | |
| Molecular Formula | C12D18O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 107.5±7.2 °C | |
| Symbol |
GHS02, GHS06, GHS08 |
Signal Word | Danger | |
| Name | 1,2,3-trideuterio-5-deuteriooxy-4,6-bis(1,1,1,2,3,3,3-heptadeuteriopropan-2-yl)benzene |
|---|---|
| Synonym | More Synonyms |
| Density | 0.9±0.1 g/cm3 |
|---|---|
| Boiling Point | 256.0±0.0 °C at 760 mmHg |
| Molecular Formula | C12D18O |
| Molecular Weight | 196.382 |
| Flash Point | 107.5±7.2 °C |
| Exact Mass | 196.248749 |
| PSA | 20.23000 |
| LogP | 4.16 |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.513 |
| Symbol |
GHS02, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H301 + H311 + H331-H370 |
| Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
| RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution |
|
WIN OVER study: Efficacy and safety of olmesartan in Indian hypertensive patients: results of an open label, non-comparative, multi-centric, post marketing observational study.
Indian Heart J. 66(3) , 340-344, (2014) Hypertension is a global health problem. Multiple classes of drugs including angiotensin receptor blockers (ARBs) are available for the treatment of hypertension. Olmesartan is a relatively newer ARB ... |
|
|
Feasibility of cisplatin/5-fluorouracil and panitumumab in Japanese patients with squamous cell carcinoma of the head and neck.
Jpn. J. Clin. Oncol. , (2014) In Japan, cisplatin/5-fluorouracil 80/800 (cisplatin 80 mg/m2, 5-fluorouracil 800 mg/m2) is widely used to treat recurrent/metastatic squamous cell carcinoma of the head and neck, whereas cisplatin/5-... |
|
|
Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period.
Br. J. Clin. Pharmacol. , doi:10.1111/bcp.12426, (2014) The purpose of this study was to develop a population pharmacokinetic and pharmacodynamic (PK-PD) model for mycophenolic acid (MPA) in paediatric renal transplant recipients in the early post-transpla... |
| 2,6-Bis[(H)-2-propanyl](O-H)phenol |
| Propofol-d18 |
| 2,6-Bis[(H)propan-2-yl](O-H)phenol |
| 2,5-ANHYDRO-2,5-IMINO-D-MANNITOL HYDROCHLORIDE |
| Phenol-3,4,5-d-d, 2,6-bis[1-(methyl-d)ethyl-1,2,2,2-d]- |